Hart-Scott-Rodino Waiting Period Expires for LabCorp Acquisition of Covance Read more about Hart-Scott-Rodino Waiting Period Expires for LabCorp Acquisition of Covance
LabCorp Announces Acquisition of Bode Technology Read more about LabCorp Announces Acquisition of Bode Technology
LabCorp Completes Acquisition of LIPOSCIENCE Read more about LabCorp Completes Acquisition of LIPOSCIENCE
LabCorp to Acquire Covance for Approximately $5.6 Billion, Creating World’s Leading Healthcare Diagnostics Company Read more about LabCorp to Acquire Covance for Approximately $5.6 Billion, Creating World’s Leading Healthcare Diagnostics Company
Laboratory Corporation of America® Holdings Announces 2014 Third Quarter Results and Increases 2014 EPS Guidance Read more about Laboratory Corporation of America® Holdings Announces 2014 Third Quarter Results and Increases 2014 EPS Guidance
LabCorp Introduces HIV-1 Next Generation Sequencing Assay to Support Drug Regimen Changes in HIV Suppressed Patients Read more about LabCorp Introduces HIV-1 Next Generation Sequencing Assay to Support Drug Regimen Changes in HIV Suppressed Patients
LabCorp’s Acquisition of LipoScience Clears Antitrust Approval Read more about LabCorp’s Acquisition of LipoScience Clears Antitrust Approval
Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021 Read more about Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
LabCorp Announces Agreement to Acquire LipoScience Read more about LabCorp Announces Agreement to Acquire LipoScience
LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest Read more about LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest
